Medicines used in mental, neurological and substance use disorders in Gauteng, South Africa: A secondary analysis of the 2017–2018 provincial pharmaceutical database, Part 1

South African Journal of Psychiatry


 
 
Field Value
 
Title Medicines used in mental, neurological and substance use disorders in Gauteng, South Africa: A secondary analysis of the 2017–2018 provincial pharmaceutical database, Part 1
 
Creator Bouwer, Jade C. Govender, Shereen Robertson, Lesley J.
 
Subject Psychiatry; Public Health essential medicines; prescribing patterns; rational use; psychopharmacology; Anatomical Therapeutic and Chemical classification/Defined Daily Doses
Description Background: Access to essential medicines is an integral part of effective health systems. Analysis of medicine procurement may assist with ensuring sustainable access.Aim: To describe the profile and cost of medicines procured for managing mental, neurological and substance use (MNS) disorders during the 2017–2018 financial year.Setting: The study was conducted in the public health sector in the Gauteng province, South Africa.Method: A secondary analysis of the Gauteng Medical Stores Administration System database was performed. Medicine procurement for managing MNS disorders was analysed descriptively by using the World Health Organization’s Anatomical Therapeutic Chemical/Defined Daily Dose (ATC/DDD) methodology. Procurement of each medicine was evaluated in local currency (Rands) and in DDD/1000 population served. The District Health Information System was used to estimate population served.Results: Of the total provincial medicines expenditure in 2017–2018, 3.73% was for MNS disorders, which is similar to the spending on cardiovascular (4%) and respiratory (3%) disorders. Antivirals for systemic use comprised 44% of the total expenditure, followed by vaccines at 13%. Of the medicines for MNS disorders, 32.5% of DDDs procured were for anti-epileptics (ATC N03A) at 47.5% of expenditure; 26.2% of DDDs were for antipsychotics (ATC N05A) at 30.9% of expenditure; and antidepressants accounted for 30.8% of DDDs at 6% of expenditure.Conclusion: Less than 4% of provincial medicines expenditure was on medicines for MNS disorders, of which almost 78.4% of expenditure was on anti-epileptics and antipsychotics. With limited financial resources, evaluation of procurement patterns raises awareness of relative costs.
 
Publisher AOSIS
 
Contributor
Date 2021-01-28
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — Secondary analysis
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/sajpsychiatry.v27i0.1552
 
Source South African Journal of Psychiatry; Vol 27 (2021); 10 pages 2078-6786 1608-9685
 
Language eng
 
Relation https://sajp.org.za/index.php/sajp/article/view/1552/1921 https://sajp.org.za/index.php/sajp/article/view/1552/1920 https://sajp.org.za/index.php/sajp/article/view/1552/1922 https://sajp.org.za/index.php/sajp/article/view/1552/1919
 
Coverage Gauteng March 2017 - February 2018 Medicines; procurement; expenditure
Rights Copyright (c) 2021 Jade C. Bouwer, Shereen Govender, Lesley J. Robertson https://creativecommons.org/licenses/by/4.0